BSE Live
Jul 31, 16:01Prev. Close
5.10
Open Price
5.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jul 31, 15:40Prev. Close
4.95
Open Price
5.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Vivimed Labs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 16.58 | 16.58 | 16.58 | 16.58 | 16.58 | |
Total Share Capital | 16.58 | 16.58 | 16.58 | 16.58 | 16.58 | |
Reserves and Surplus | 41.91 | 34.83 | 78.73 | 402.69 | 469.89 | |
Total Reserves and Surplus | 41.91 | 72.83 | 116.73 | 440.69 | 507.89 | |
Total Shareholders Funds | 58.49 | 89.41 | 133.32 | 457.27 | 524.47 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 63.32 | 63.32 | 61.98 | 60.61 | 57.10 | |
Deferred Tax Liabilities [Net] | 9.03 | 9.03 | 9.03 | 11.15 | 8.33 | |
Other Long Term Liabilities | 110.56 | 124.47 | 168.14 | 168.89 | 168.53 | |
Long Term Provisions | 4.35 | 4.07 | 3.95 | 8.04 | 6.40 | |
Total Non-Current Liabilities | 187.26 | 200.89 | 243.11 | 248.69 | 240.37 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 311.51 | 312.16 | 314.66 | 296.33 | 193.70 | |
Trade Payables | 33.65 | 38.84 | 70.57 | 37.41 | 32.89 | |
Other Current Liabilities | 46.64 | 38.97 | 29.53 | 31.66 | 102.55 | |
Short Term Provisions | 1.42 | 1.21 | 1.07 | 0.43 | 0.86 | |
Total Current Liabilities | 393.21 | 391.17 | 415.83 | 365.82 | 330.00 | |
Total Capital And Liabilities | 638.95 | 681.47 | 792.25 | 1,071.79 | 1,094.83 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 247.87 | 257.61 | 272.23 | 355.93 | 341.37 | |
Intangible Assets | 67.41 | 68.71 | 70.63 | 72.88 | 75.13 | |
Capital Work-In-Progress | 17.11 | 20.65 | 20.67 | 40.03 | 58.45 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 332.39 | 346.97 | 363.53 | 468.84 | 474.95 | |
Non-Current Investments | 58.78 | 58.78 | 161.14 | 161.14 | 161.14 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Assets | 391.18 | 405.75 | 524.66 | 629.97 | 636.09 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 56.50 | 62.77 | 78.31 | 239.07 | 253.68 | |
Trade Receivables | 45.80 | 59.54 | 52.96 | 63.39 | 76.70 | |
Cash And Cash Equivalents | 0.29 | 1.14 | 3.35 | 6.78 | 6.02 | |
Short Term Loans And Advances | 5.42 | 1.90 | 3.04 | 4.23 | 58.53 | |
OtherCurrentAssets | 139.76 | 150.37 | 129.94 | 128.35 | 63.82 | |
Total Current Assets | 247.78 | 275.72 | 267.59 | 441.82 | 458.75 | |
Total Assets | 638.95 | 681.47 | 792.25 | 1,071.79 | 1,094.83 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 115.69 | 123.42 | 215.57 | 220.66 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.00 | 0.68 | 0.00 | 0.04 | 31.22 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | -- | 14.30 | 1.66 | 0.02 | 35.65 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | 58.78 | 161.14 | 161.14 | 161.14 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
04.03.2025
Vivimed Labs Consolidated December 2024 Net Sales at Rs 36.51 crore, down 11.94% Y-o-Y
16.02.2024
Vivimed Labs Standalone December 2023 Net Sales at Rs 37.14 crore, down 26.55% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
04.03.2025
Vivimed Labs Consolidated December 2024 Net Sales at Rs 36.51 crore, down 11.94% Y-o-Y
16.02.2024
Vivimed Labs Standalone December 2023 Net Sales at Rs 37.14 crore, down 26.55% Y-o-Y